Literature DB >> 24172850

Parapneumonic pleural effusions caused by Streptococcus pneumoniae serotype 3 in children immunized with 13-valent conjugated pneumococcal vaccine.

Charalampos Antachopoulos1, Maria N Tsolia, Georgina Tzanakaki, Athanasia Xirogianni, Olga Dedousi, Georgia Markou, Sofia-Maria Zografou, Andreas Eliades, Fotis Kirvassilis, Konstantinos Kesanopoulos, Emmanuel Roilides.   

Abstract

During 2012, Streptococcus pneumoniae serotype 3 was identified by polymerase chain reaction in 15 out of 20 (75%) pleural fluid specimens from children with pneumococcal pneumonia complicated by parapneumonic pleural effusion in Greece. One-third of these children had been immunized with the 13-valent conjugated pneumococcal vaccine after the age of 12 months, according to the national immunization schedule.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24172850     DOI: 10.1097/INF.0000000000000041

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  14 in total

1.  Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain.

Authors:  Susanna Hernández-Bou; Borja Gómez; Santiago Mintegi; Juan J García-García
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-07       Impact factor: 3.267

2.  Evaluation of Protective Efficacy of Selected Immunodominant B-Cell Epitopes within Virulent Surface Proteins of Streptococcus pneumoniae.

Authors:  Theodora Papastamatiou; John G Routsias; Olga Koutsoni; Eleni Dotsika; Athanassios Tsakris; Vana Spoulou
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

3.  Serotype 19A Bacteremic Pneumococcal Pneumonia After 4 Doses of 13-Valent Conjugate Vaccine: A Review of Pneumococcal Conjugate Vaccine Effectiveness.

Authors:  Pui-Ying Iroh Tam; Benjamin R Hanisch; Brennan Forward
Journal:  Clin Pediatr (Phila)       Date:  2014-12-10       Impact factor: 1.168

4.  Direct Streptococcus pneumoniae real-time PCR serotyping from pediatric parapneumonic effusions.

Authors:  Robert Slinger; Lucie Hyde; Ioana Moldovan; Francis Chan; Jeffrey M Pernica
Journal:  BMC Pediatr       Date:  2014-07-24       Impact factor: 2.125

5.  Metabolomic Profiling of Infectious Parapneumonic Effusions Reveals Biomarkers for Guiding Management of Children with Streptococcus pneumoniae Pneumonia.

Authors:  Chih-Yung Chiu; Gigin Lin; Mei-Ling Cheng; Meng-Han Chiang; Ming-Han Tsai; Shen-Hao Lai; Kin-Sun Wong; Sen-Yung Hsieh
Journal:  Sci Rep       Date:  2016-04-22       Impact factor: 4.379

6.  A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine.

Authors:  Idrissa Diawara; Khalid Zerouali; Naima Elmdaghri; Abderrahman Abid
Journal:  BMC Pediatr       Date:  2017-04-27       Impact factor: 2.125

7.  Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.

Authors:  Ángela Domínguez; Pilar Ciruela; Sergi Hernández; Juan José García-García; Núria Soldevila; Conchita Izquierdo; Fernando Moraga-Llop; Alvaro Díaz; Mariona F de Sevilla; Sebastià González-Peris; Magda Campins; Sonia Uriona; Johanna Martínez-Osorio; Anna Solé-Ribalta; Gemma Codina; Cristina Esteva; Ana María Planes; Carmen Muñoz-Almagro; Luis Salleras
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

8.  Empyema due to Streptococcus Pneumoniae Serotype 9V in a Child Immunized with 13-Valent Conjugated Pneumococcal Vaccine.

Authors:  Murat Sütçü; Hacer Aktürk; Fatih Karagözlü; Ayper Somer; Nezahat Gürler; Nuran Salman
Journal:  Balkan Med J       Date:  2017-01-05       Impact factor: 2.021

9.  PCV13 vaccination impact: A multicenter study of pneumonia in 10 pediatric hospitals in Argentina.

Authors:  Angela Gentile; Julia Bakir; Verónica Firpo; Enrique V Casanueva; Gabriela Ensinck; Santiago Lopez Papucci; María F Lución; Hector Abate; Aldo Cancellara; Fabiana Molina; Andrea Gajo Gane; Alfredo M Caruso; Alejandro Santillán Iturres; Sofía Fossati
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

10.  Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2-59 Months of Age, Spain.

Authors:  Sergi Hernández; Fernando Moraga-Llop; Alvaro Díaz; Mariona F de Sevilla; Pilar Ciruela; Carmen Muñoz-Almagro; Gemma Codina; Magda Campins; Juan José García-García; Cristina Esteva; Conchita Izquierdo; Sebastià González-Peris; Johanna Martínez-Osorio; Sonia Uriona; Luis Salleras; Ángela Domínguez
Journal:  Emerg Infect Dis       Date:  2020-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.